Assignee
RELEVALE INC
US·4 granted patents·1 pending application·13 citations·filing 2019–2025
Top patents by PatentIndex Score
5 records- 0191US11541043B2Low concentration delivery of an ergoline derivative for treatment of a headacheRELEVALE INC·Filed 2022·Granted Jan 3, 2023·2 cites·20 claims
- 0290US11083712B1Low concentration delivery of an ergoline derivative for treatment of a headacheRELEVALE INC·Filed 2019·Granted Aug 10, 2021·11 cites·36 claims
- 0385US2025381170A1Low Concentration Delivery of an Ergoline Derivative for Treatment of a HeadacheRELEVALE INC·Filed 2025·Application pending·0 cites
- 0478US12414941B2Low concentration delivery of an ergoline derivative for treatment of a headacheRELEVALE INC·Filed 2022·Granted Sep 16, 2025·0 cites·18 claims
- 0573US12329749B2Low concentration delivery of an ergoline derivative for treatment of a headacheRELEVALE INC·Filed 2021·Granted Jun 17, 2025·0 cites·15 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →